CD8A and neoplasm: Together, these immune components constitute a dynamic ecosystem where the balance between antitumor immunity mediated by factors such as CD8+ T cells and tertiary lymphoid structure formation, and immunosuppressive mechanisms involving regulatory T cells, myeloid-derived suppressor cells, tumor-associated macrophages and checkpoint engagement dictates disease evolution and therapeutic outcomes (51, 52).